Survey of Adult Participants Enrolled in Decentralized Clinical Trials
NCT06751641 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-01-16
Summary
Clinical trials (CTs) have become increasingly complex, requiring significant commitment from participants. Decentralized clinical trials (DCTs) offer an alternative by shifting some activities away from traditional sites to locations like the patient's home. This reduces the burden on participants, improves accessibility, and enhances recruitment and retention rates.
DCTs leverage digital tools such as telemedicine, electronic consent, and wearable devices for data collection. These methods enable fewer site visits, lowering costs and integrating trials more seamlessly into participants' daily routines.
This survey aims to assess the willingness of participants already enrolled in traditional CTs to engage in DCTs. Their prior experience with trial procedures allows them to provide valuable insights into the perceived benefits and feasibility of decentralized elements.
Conditions
- Clinical Trial Incorporating Decentralized Elements
Interventions
- OTHER
-
patient participating in a clinical trial incorporating decentralized elements.
participating in a clinical trial incorporating decentralized elements.
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Principal Investigators
-
Laurent Flet, PharmD · Nantes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-05
- Primary Completion
- 2025-06-05
- Completion
- 2025-06-05
Countries
- France
Study Locations
More Related Trials
-
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
NCT06340828 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Symptomatic Treatment of Acute Gastroenteritis
NCT01257672 ·Status: COMPLETED ·Phase: PHASE3
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217 ·Status: RECRUITING ·Phase: NA
-
Open-label, Normal Healthy Volunteer Clinical Trial of a Novel Ondansetron Formulation
NCT01290276 ·Status: COMPLETED ·Phase: PHASE1
-
Ginger Control of Chemotherapy Induced Nausea and Vomiting
NCT00065221 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial
NCT04318847 ·Status: UNKNOWN ·Phase: PHASE4
-
Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
NCT00934921 ·Status: COMPLETED ·Phase: PHASE1
-
Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting
NCT00642512 ·Status: COMPLETED ·Phase: PHASE3
-
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
NCT03675321 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)
NCT00972595 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
NCT01084473 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition
NCT01578252 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
NCT00418678 ·Status: TERMINATED ·Phase: PHASE4
-
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
NCT00005994 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
NCT01578265 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
NCT06371014 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
NCT00040742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
NCT00003817 ·Status: COMPLETED ·Phase: PHASE2
-
Ondansetron and the QT Interval In Adult Emergency Department Patients
NCT01759420 ·Status: COMPLETED
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Domperidone in Treating Patients With Gastrointestinal Disorders
NCT01696734 ·Status: RECRUITING ·Phase: PHASE3
-
Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting
NCT00360841 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00492037 ·Status: COMPLETED ·Phase: PHASE3